• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素驱动在多囊卵巢综合征病理生理学中的作用

Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

作者信息

Leondires M P, Berga S L

机构信息

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, USA.

出版信息

J Endocrinol Invest. 1998 Jul-Aug;21(7):476-85. doi: 10.1007/BF03347331.

DOI:10.1007/BF03347331
PMID:9766266
Abstract

Polycystic ovary syndrome may result from multiple mechanisms, but full expression of the PCO syndrome with hyperandrogenic anovulation depends upon sustained LH drive and relative FSH deficiency. We have described possible intrinsic and extrinsic factors capable of modifying the hypothalamic-pituitary-ovarian axis. Available evidence suggests the presence of an intrinsic alteration in GnRH-LH drive. The long-term natural history of HAA is variable and depends on several factors including obesity, aberrations in insulin action, intrinsic ovarian function, and end-organ responsiveness to androgens. Figure 1 presents a conceptualization of the pathogenesis of PCOS diagramming the multiple modulators of its expression. Long-term suppression of androgens when fertility is not desired should modify the full expression of the PCO syndrome. It is important to appreciate that therapy with oral contraceptive agents has few drawbacks and many immediate and potential long-term benefits for women with HAA. This therapy may be of greatest benefit when started in adolescence prior to the progression of obesity, hirsutism, and thecal-stromal hyperplasia. Women with HAA represent a large subgroup of patients who require individualization of their health care with sensitivity to issues surrounding anovulation, obesity, hirsutism, and infertility.

摘要

多囊卵巢综合征可能由多种机制引起,但伴有高雄激素性无排卵的多囊卵巢综合征的完全表现取决于持续的促黄体生成素(LH)驱动和相对的促卵泡生成素(FSH)缺乏。我们已经描述了可能影响下丘脑-垂体-卵巢轴的内在和外在因素。现有证据表明促性腺激素释放激素(GnRH)-LH驱动存在内在改变。高雄激素性无排卵(HAA)的长期自然病程是可变的,并且取决于几个因素,包括肥胖、胰岛素作用异常、卵巢内在功能以及终末器官对雄激素的反应性。图1展示了多囊卵巢综合征(PCOS)发病机制的概念图,描绘了其表达的多种调节因素。当不期望生育时,长期抑制雄激素应能改变多囊卵巢综合征的完全表现。重要的是要认识到,口服避孕药治疗对高雄激素性无排卵的女性几乎没有缺点,而且有许多直接和潜在的长期益处。这种治疗在青春期肥胖、多毛症和卵泡膜-间质增生进展之前开始可能益处最大。高雄激素性无排卵的女性代表了一大类患者群体,她们需要针对无排卵、肥胖、多毛症和不孕等问题进行个体化的医疗保健。

相似文献

1
Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.促性腺激素释放激素驱动在多囊卵巢综合征病理生理学中的作用
J Endocrinol Invest. 1998 Jul-Aug;21(7):476-85. doi: 10.1007/BF03347331.
2
Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?多囊卵巢综合征能否在不伴有下丘脑功能障碍的情况下存在?
Semin Reprod Endocrinol. 1997 May;15(2):169-75. doi: 10.1055/s-2007-1016298.
3
Ovulatory disorders in women with polycystic ovary syndrome.多囊卵巢综合征女性的排卵障碍
Clin Obstet Gynaecol. 1985 Sep;12(3):605-32.
4
Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.促性腺激素分泌的调节:对多囊卵巢综合征的影响
Semin Reprod Med. 2002 Nov;20(4):317-26. doi: 10.1055/s-2002-36706.
5
Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.患有少/闭经和多囊卵巢的女性,无论其雄激素状态如何,对促性腺激素释放激素(GnRH)刺激的反应均相同:鹿特丹和雄激素过多协会诊断标准的比较
Neuro Endocrinol Lett. 2011;32(6):847-56.
6
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.基于鹿特丹标准的多囊卵巢综合征病例与仅有少排卵/无排卵或多毛症等临床体征的女性的临床和实验室特征比较。
Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12.
7
Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation.高雄激素性无排卵中促性腺激素释放激素驱动对性类固醇诱导抑制的抵抗
J Clin Endocrinol Metab. 1997 Dec;82(12):4179-83. doi: 10.1210/jcem.82.12.4402.
8
Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.患有多囊卵巢的正常排卵女性在促性腺激素释放激素激动剂测试中对垂体-卵巢有高雄激素反应。
J Clin Endocrinol Metab. 2000 Mar;85(3):995-1000. doi: 10.1210/jcem.85.3.6452.
9
Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.多囊卵巢综合征中促黄体生成素与体重指数的负相关关系:下丘脑和垂体作用的研究
J Clin Endocrinol Metab. 2006 Apr;91(4):1309-16. doi: 10.1210/jc.2005-2099. Epub 2006 Jan 24.
10
What every physician should know about polycystic ovary syndrome.每位医生都应该了解的多囊卵巢综合征知识。
Dermatol Ther. 2008 Sep-Oct;21(5):354-61. doi: 10.1111/j.1529-8019.2008.00217.x.

本文引用的文献

1
Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.多囊卵巢综合征:促性腺激素释放激素脉冲发生器对雌二醇和孕酮抑制作用敏感性降低的证据。
J Clin Endocrinol Metab. 1998 Feb;83(2):582-90. doi: 10.1210/jcem.83.2.4604.
2
Hormonal effects of flutamide in young women with polycystic ovary syndrome.氟他胺对患有多囊卵巢综合征年轻女性的激素影响。
J Clin Endocrinol Metab. 1998 Jan;83(1):99-102. doi: 10.1210/jcem.83.1.4500.
3
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
胰岛素抵抗与多囊卵巢综合征:发病机制及意义
Endocr Rev. 1997 Dec;18(6):774-800. doi: 10.1210/edrv.18.6.0318.
4
Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation.高雄激素性无排卵中促性腺激素释放激素驱动对性类固醇诱导抑制的抵抗
J Clin Endocrinol Metab. 1997 Dec;82(12):4179-83. doi: 10.1210/jcem.82.12.4402.
5
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.临床诊断为多囊卵巢综合征女性促性腺激素分泌异常的决定因素
J Clin Endocrinol Metab. 1997 Jul;82(7):2248-56. doi: 10.1210/jcem.82.7.4105.
6
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.曲格列酮可改善多囊卵巢综合征女性的胰岛素作用、胰岛素分泌、卵巢甾体激素生成及纤维蛋白溶解功能缺陷。
J Clin Endocrinol Metab. 1997 Jul;82(7):2108-16. doi: 10.1210/jcem.82.7.4069.
7
Serum leptin concentrations in women with polycystic ovary syndrome.多囊卵巢综合征女性的血清瘦素浓度
J Clin Endocrinol Metab. 1997 Jun;82(6):1697-700. doi: 10.1210/jcem.82.6.3996.
8
Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.多囊卵巢综合征女性的血清瘦素水平:胰岛素抵抗/高胰岛素血症的作用
J Clin Endocrinol Metab. 1997 Jun;82(6):1692-6. doi: 10.1210/jcem.82.6.4028.
9
Leptin concentrations in the polycystic ovary syndrome.多囊卵巢综合征中的瘦素浓度
J Clin Endocrinol Metab. 1997 Jun;82(6):1687-91. doi: 10.1210/jcem.82.6.4017.
10
Congenital adrenal hyperplasia.先天性肾上腺增生症
Curr Ther Endocrinol Metab. 1997;6:179-87.